0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Genetically Engineered Vaccines for Livestock Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-35K13763
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Genetically Engineered Vaccines for Livestock Market Research Report 2023
BUY CHAPTERS

Global Genetically Engineered Vaccines for Livestock Market Research Report 2025

Code: QYRE-Auto-35K13763
Report
May 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Genetically Engineered Vaccines for Livestock Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Genetically Engineered Vaccines for Livestock Market

Genetically Engineered Vaccines for Livestock Market

The global market for Genetically Engineered Vaccines for Livestock was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Genetically Engineered Vaccines for Livestock, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetically Engineered Vaccines for Livestock.
The Genetically Engineered Vaccines for Livestock market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genetically Engineered Vaccines for Livestock market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetically Engineered Vaccines for Livestock manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Genetically Engineered Vaccines for Livestock Market Report

Report Metric Details
Report Name Genetically Engineered Vaccines for Livestock Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, GSK, Sanofi, Zoties, Elanco, Boehringer Ingelheim, Indian Immunologicals, China Animal Husbandry Industry Co.,Ltd., Yebio Bioengineering Co., Ltd Of Qingdao, Jinyu Bio-technology Co.,ltd., HVRI, Ringpu Biology, Kyoto Biken Laboratories, FATRO, Ceva Santé Animale, Pulike Biological Engineering,Inc., Wuhan Hvsen Biotechnology CO.,LTD, Jinhe Biotechnology Co., Ltd., Shanghai Shen Lian Biomedical Corporation, Qingdao Vland Biotech INC.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Genetically Engineered Vaccines for Livestock manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Genetically Engineered Vaccines for Livestock in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Genetically Engineered Vaccines for Livestock Market report?

Ans: The main players in the Genetically Engineered Vaccines for Livestock Market are Merck, GSK, Sanofi, Zoties, Elanco, Boehringer Ingelheim, Indian Immunologicals, China Animal Husbandry Industry Co.,Ltd., Yebio Bioengineering Co., Ltd Of Qingdao, Jinyu Bio-technology Co.,ltd., HVRI, Ringpu Biology, Kyoto Biken Laboratories, FATRO, Ceva Santé Animale, Pulike Biological Engineering,Inc., Wuhan Hvsen Biotechnology CO.,LTD, Jinhe Biotechnology Co., Ltd., Shanghai Shen Lian Biomedical Corporation, Qingdao Vland Biotech INC.

What are the Application segmentation covered in the Genetically Engineered Vaccines for Livestock Market report?

Ans: The Applications covered in the Genetically Engineered Vaccines for Livestock Market report are Pig, Cattle, Sheep, Other

What are the Type segmentation covered in the Genetically Engineered Vaccines for Livestock Market report?

Ans: The Types covered in the Genetically Engineered Vaccines for Livestock Market report are Genetic Recombinant Vaccine, Recombinant Subunit Vaccines, Genetic Vaccine

Recommended Reports

Veterinary Vaccines

Human Vaccine Markets

Recombinant & mRNA Vaccines

1 Genetically Engineered Vaccines for Livestock Market Overview
1.1 Product Definition
1.2 Genetically Engineered Vaccines for Livestock by Type
1.2.1 Global Genetically Engineered Vaccines for Livestock Market Value Comparison by Type (2024 VS 2031)
1.2.2 Genetic Recombinant Vaccine
1.2.3 Recombinant Subunit Vaccines
1.2.4 Genetic Vaccine
1.3 Genetically Engineered Vaccines for Livestock by Application
1.3.1 Global Genetically Engineered Vaccines for Livestock Market Value by Application (2024 VS 2031)
1.3.2 Pig
1.3.3 Cattle
1.3.4 Sheep
1.3.5 Other
1.4 Global Genetically Engineered Vaccines for Livestock Market Size Estimates and Forecasts
1.4.1 Global Genetically Engineered Vaccines for Livestock Revenue 2020-2031
1.4.2 Global Genetically Engineered Vaccines for Livestock Sales 2020-2031
1.4.3 Global Genetically Engineered Vaccines for Livestock Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Genetically Engineered Vaccines for Livestock Market Competition by Manufacturers
2.1 Global Genetically Engineered Vaccines for Livestock Sales Market Share by Manufacturers (2020-2025)
2.2 Global Genetically Engineered Vaccines for Livestock Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Genetically Engineered Vaccines for Livestock Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Genetically Engineered Vaccines for Livestock, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genetically Engineered Vaccines for Livestock, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genetically Engineered Vaccines for Livestock, Product Type & Application
2.7 Global Key Manufacturers of Genetically Engineered Vaccines for Livestock, Date of Enter into This Industry
2.8 Global Genetically Engineered Vaccines for Livestock Market Competitive Situation and Trends
2.8.1 Global Genetically Engineered Vaccines for Livestock Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Genetically Engineered Vaccines for Livestock Players Market Share by Revenue
2.8.3 Global Genetically Engineered Vaccines for Livestock Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Genetically Engineered Vaccines for Livestock Market Scenario by Region
3.1 Global Genetically Engineered Vaccines for Livestock Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Genetically Engineered Vaccines for Livestock Sales by Region: 2020-2031
3.2.1 Global Genetically Engineered Vaccines for Livestock Sales by Region: 2020-2025
3.2.2 Global Genetically Engineered Vaccines for Livestock Sales by Region: 2026-2031
3.3 Global Genetically Engineered Vaccines for Livestock Revenue by Region: 2020-2031
3.3.1 Global Genetically Engineered Vaccines for Livestock Revenue by Region: 2020-2025
3.3.2 Global Genetically Engineered Vaccines for Livestock Revenue by Region: 2026-2031
3.4 North America Genetically Engineered Vaccines for Livestock Market Facts & Figures by Country
3.4.1 North America Genetically Engineered Vaccines for Livestock Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Genetically Engineered Vaccines for Livestock Sales by Country (2020-2031)
3.4.3 North America Genetically Engineered Vaccines for Livestock Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Genetically Engineered Vaccines for Livestock Market Facts & Figures by Country
3.5.1 Europe Genetically Engineered Vaccines for Livestock Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Genetically Engineered Vaccines for Livestock Sales by Country (2020-2031)
3.5.3 Europe Genetically Engineered Vaccines for Livestock Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genetically Engineered Vaccines for Livestock Market Facts & Figures by Region
3.6.1 Asia Pacific Genetically Engineered Vaccines for Livestock Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Genetically Engineered Vaccines for Livestock Sales by Region (2020-2031)
3.6.3 Asia Pacific Genetically Engineered Vaccines for Livestock Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Genetically Engineered Vaccines for Livestock Market Facts & Figures by Country
3.7.1 Latin America Genetically Engineered Vaccines for Livestock Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Genetically Engineered Vaccines for Livestock Sales by Country (2020-2031)
3.7.3 Latin America Genetically Engineered Vaccines for Livestock Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genetically Engineered Vaccines for Livestock Market Facts & Figures by Country
3.8.1 Middle East and Africa Genetically Engineered Vaccines for Livestock Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Genetically Engineered Vaccines for Livestock Sales by Country (2020-2031)
3.8.3 Middle East and Africa Genetically Engineered Vaccines for Livestock Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genetically Engineered Vaccines for Livestock Sales by Type (2020-2031)
4.1.1 Global Genetically Engineered Vaccines for Livestock Sales by Type (2020-2025)
4.1.2 Global Genetically Engineered Vaccines for Livestock Sales by Type (2026-2031)
4.1.3 Global Genetically Engineered Vaccines for Livestock Sales Market Share by Type (2020-2031)
4.2 Global Genetically Engineered Vaccines for Livestock Revenue by Type (2020-2031)
4.2.1 Global Genetically Engineered Vaccines for Livestock Revenue by Type (2020-2025)
4.2.2 Global Genetically Engineered Vaccines for Livestock Revenue by Type (2026-2031)
4.2.3 Global Genetically Engineered Vaccines for Livestock Revenue Market Share by Type (2020-2031)
4.3 Global Genetically Engineered Vaccines for Livestock Price by Type (2020-2031)
5 Segment by Application
5.1 Global Genetically Engineered Vaccines for Livestock Sales by Application (2020-2031)
5.1.1 Global Genetically Engineered Vaccines for Livestock Sales by Application (2020-2025)
5.1.2 Global Genetically Engineered Vaccines for Livestock Sales by Application (2026-2031)
5.1.3 Global Genetically Engineered Vaccines for Livestock Sales Market Share by Application (2020-2031)
5.2 Global Genetically Engineered Vaccines for Livestock Revenue by Application (2020-2031)
5.2.1 Global Genetically Engineered Vaccines for Livestock Revenue by Application (2020-2025)
5.2.2 Global Genetically Engineered Vaccines for Livestock Revenue by Application (2026-2031)
5.2.3 Global Genetically Engineered Vaccines for Livestock Revenue Market Share by Application (2020-2031)
5.3 Global Genetically Engineered Vaccines for Livestock Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Genetically Engineered Vaccines for Livestock Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Genetically Engineered Vaccines for Livestock Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Genetically Engineered Vaccines for Livestock Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Company Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zoties Genetically Engineered Vaccines for Livestock Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Company Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Elanco Genetically Engineered Vaccines for Livestock Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Company Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boehringer Ingelheim Genetically Engineered Vaccines for Livestock Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.7.1 Indian Immunologicals Company Information
6.7.2 Indian Immunologicals Description and Business Overview
6.7.3 Indian Immunologicals Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Indian Immunologicals Genetically Engineered Vaccines for Livestock Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 China Animal Husbandry Industry Co.,Ltd.
6.8.1 China Animal Husbandry Industry Co.,Ltd. Company Information
6.8.2 China Animal Husbandry Industry Co.,Ltd. Description and Business Overview
6.8.3 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.8.4 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines for Livestock Product Portfolio
6.8.5 China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
6.9 Yebio Bioengineering Co., Ltd Of Qingdao
6.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
6.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Description and Business Overview
6.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines for Livestock Product Portfolio
6.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
6.10 Jinyu Bio-technology Co.,ltd.
6.10.1 Jinyu Bio-technology Co.,ltd. Company Information
6.10.2 Jinyu Bio-technology Co.,ltd. Description and Business Overview
6.10.3 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines for Livestock Product Portfolio
6.10.5 Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
6.11 HVRI
6.11.1 HVRI Company Information
6.11.2 HVRI Description and Business Overview
6.11.3 HVRI Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.11.4 HVRI Genetically Engineered Vaccines for Livestock Product Portfolio
6.11.5 HVRI Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Company Information
6.12.2 Ringpu Biology Description and Business Overview
6.12.3 Ringpu Biology Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Ringpu Biology Genetically Engineered Vaccines for Livestock Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 Kyoto Biken Laboratories
6.13.1 Kyoto Biken Laboratories Company Information
6.13.2 Kyoto Biken Laboratories Description and Business Overview
6.13.3 Kyoto Biken Laboratories Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Kyoto Biken Laboratories Genetically Engineered Vaccines for Livestock Product Portfolio
6.13.5 Kyoto Biken Laboratories Recent Developments/Updates
6.14 FATRO
6.14.1 FATRO Company Information
6.14.2 FATRO Description and Business Overview
6.14.3 FATRO Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.14.4 FATRO Genetically Engineered Vaccines for Livestock Product Portfolio
6.14.5 FATRO Recent Developments/Updates
6.15 Ceva Santé Animale
6.15.1 Ceva Santé Animale Company Information
6.15.2 Ceva Santé Animale Description and Business Overview
6.15.3 Ceva Santé Animale Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Ceva Santé Animale Genetically Engineered Vaccines for Livestock Product Portfolio
6.15.5 Ceva Santé Animale Recent Developments/Updates
6.16 Pulike Biological Engineering,Inc.
6.16.1 Pulike Biological Engineering,Inc. Company Information
6.16.2 Pulike Biological Engineering,Inc. Description and Business Overview
6.16.3 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Livestock Product Portfolio
6.16.5 Pulike Biological Engineering,Inc. Recent Developments/Updates
6.17 Wuhan Hvsen Biotechnology CO.,LTD
6.17.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
6.17.2 Wuhan Hvsen Biotechnology CO.,LTD Description and Business Overview
6.17.3 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Livestock Product Portfolio
6.17.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
6.18 Jinhe Biotechnology Co., Ltd.
6.18.1 Jinhe Biotechnology Co., Ltd. Company Information
6.18.2 Jinhe Biotechnology Co., Ltd. Description and Business Overview
6.18.3 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Livestock Product Portfolio
6.18.5 Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
6.19 Shanghai Shen Lian Biomedical Corporation
6.19.1 Shanghai Shen Lian Biomedical Corporation Company Information
6.19.2 Shanghai Shen Lian Biomedical Corporation Description and Business Overview
6.19.3 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines for Livestock Product Portfolio
6.19.5 Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
6.20 Qingdao Vland Biotech INC.
6.20.1 Qingdao Vland Biotech INC. Company Information
6.20.2 Qingdao Vland Biotech INC. Description and Business Overview
6.20.3 Qingdao Vland Biotech INC. Genetically Engineered Vaccines for Livestock Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Qingdao Vland Biotech INC. Genetically Engineered Vaccines for Livestock Product Portfolio
6.20.5 Qingdao Vland Biotech INC. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genetically Engineered Vaccines for Livestock Industry Chain Analysis
7.2 Genetically Engineered Vaccines for Livestock Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genetically Engineered Vaccines for Livestock Production Mode & Process Analysis
7.4 Genetically Engineered Vaccines for Livestock Sales and Marketing
7.4.1 Genetically Engineered Vaccines for Livestock Sales Channels
7.4.2 Genetically Engineered Vaccines for Livestock Distributors
7.5 Genetically Engineered Vaccines for Livestock Customer Analysis
8 Genetically Engineered Vaccines for Livestock Market Dynamics
8.1 Genetically Engineered Vaccines for Livestock Industry Trends
8.2 Genetically Engineered Vaccines for Livestock Market Drivers
8.3 Genetically Engineered Vaccines for Livestock Market Challenges
8.4 Genetically Engineered Vaccines for Livestock Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Genetically Engineered Vaccines for Livestock Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Genetically Engineered Vaccines for Livestock Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Genetically Engineered Vaccines for Livestock Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Genetically Engineered Vaccines for Livestock Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Genetically Engineered Vaccines for Livestock Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Genetically Engineered Vaccines for Livestock Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Genetically Engineered Vaccines for Livestock Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Genetically Engineered Vaccines for Livestock Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Genetically Engineered Vaccines for Livestock, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Genetically Engineered Vaccines for Livestock, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Genetically Engineered Vaccines for Livestock, Product Type & Application
 Table 12. Global Key Manufacturers of Genetically Engineered Vaccines for Livestock, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Genetically Engineered Vaccines for Livestock by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Engineered Vaccines for Livestock as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Genetically Engineered Vaccines for Livestock Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Genetically Engineered Vaccines for Livestock Sales by Region (2020-2025) & (K Units)
 Table 18. Global Genetically Engineered Vaccines for Livestock Sales Market Share by Region (2020-2025)
 Table 19. Global Genetically Engineered Vaccines for Livestock Sales by Region (2026-2031) & (K Units)
 Table 20. Global Genetically Engineered Vaccines for Livestock Sales Market Share by Region (2026-2031)
 Table 21. Global Genetically Engineered Vaccines for Livestock Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Genetically Engineered Vaccines for Livestock Revenue Market Share by Region (2020-2025)
 Table 23. Global Genetically Engineered Vaccines for Livestock Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Genetically Engineered Vaccines for Livestock Revenue Market Share by Region (2026-2031)
 Table 25. North America Genetically Engineered Vaccines for Livestock Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Genetically Engineered Vaccines for Livestock Sales by Country (2020-2025) & (K Units)
 Table 27. North America Genetically Engineered Vaccines for Livestock Sales by Country (2026-2031) & (K Units)
 Table 28. North America Genetically Engineered Vaccines for Livestock Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Genetically Engineered Vaccines for Livestock Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Genetically Engineered Vaccines for Livestock Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Genetically Engineered Vaccines for Livestock Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Genetically Engineered Vaccines for Livestock Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Genetically Engineered Vaccines for Livestock Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Genetically Engineered Vaccines for Livestock Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Genetically Engineered Vaccines for Livestock Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Genetically Engineered Vaccines for Livestock Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Genetically Engineered Vaccines for Livestock Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Genetically Engineered Vaccines for Livestock Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Genetically Engineered Vaccines for Livestock Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Genetically Engineered Vaccines for Livestock Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Genetically Engineered Vaccines for Livestock Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Genetically Engineered Vaccines for Livestock Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Genetically Engineered Vaccines for Livestock Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Genetically Engineered Vaccines for Livestock Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Genetically Engineered Vaccines for Livestock Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Genetically Engineered Vaccines for Livestock Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Genetically Engineered Vaccines for Livestock Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Genetically Engineered Vaccines for Livestock Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Genetically Engineered Vaccines for Livestock Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Genetically Engineered Vaccines for Livestock Sales (K Units) by Type (2020-2025)
 Table 51. Global Genetically Engineered Vaccines for Livestock Sales (K Units) by Type (2026-2031)
 Table 52. Global Genetically Engineered Vaccines for Livestock Sales Market Share by Type (2020-2025)
 Table 53. Global Genetically Engineered Vaccines for Livestock Sales Market Share by Type (2026-2031)
 Table 54. Global Genetically Engineered Vaccines for Livestock Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Genetically Engineered Vaccines for Livestock Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Genetically Engineered Vaccines for Livestock Revenue Market Share by Type (2020-2025)
 Table 57. Global Genetically Engineered Vaccines for Livestock Revenue Market Share by Type (2026-2031)
 Table 58. Global Genetically Engineered Vaccines for Livestock Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Genetically Engineered Vaccines for Livestock Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Genetically Engineered Vaccines for Livestock Sales (K Units) by Application (2020-2025)
 Table 61. Global Genetically Engineered Vaccines for Livestock Sales (K Units) by Application (2026-2031)
 Table 62. Global Genetically Engineered Vaccines for Livestock Sales Market Share by Application (2020-2025)
 Table 63. Global Genetically Engineered Vaccines for Livestock Sales Market Share by Application (2026-2031)
 Table 64. Global Genetically Engineered Vaccines for Livestock Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Genetically Engineered Vaccines for Livestock Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Genetically Engineered Vaccines for Livestock Revenue Market Share by Application (2020-2025)
 Table 67. Global Genetically Engineered Vaccines for Livestock Revenue Market Share by Application (2026-2031)
 Table 68. Global Genetically Engineered Vaccines for Livestock Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Genetically Engineered Vaccines for Livestock Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Genetically Engineered Vaccines for Livestock Product
 Table 74. Merck Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK Genetically Engineered Vaccines for Livestock Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Genetically Engineered Vaccines for Livestock Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Zoties Company Information
 Table 86. Zoties Description and Business Overview
 Table 87. Zoties Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Zoties Genetically Engineered Vaccines for Livestock Product
 Table 89. Zoties Recent Developments/Updates
 Table 90. Elanco Company Information
 Table 91. Elanco Description and Business Overview
 Table 92. Elanco Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Elanco Genetically Engineered Vaccines for Livestock Product
 Table 94. Elanco Recent Developments/Updates
 Table 95. Boehringer Ingelheim Company Information
 Table 96. Boehringer Ingelheim Description and Business Overview
 Table 97. Boehringer Ingelheim Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Boehringer Ingelheim Genetically Engineered Vaccines for Livestock Product
 Table 99. Boehringer Ingelheim Recent Developments/Updates
 Table 100. Indian Immunologicals Company Information
 Table 101. Indian Immunologicals Description and Business Overview
 Table 102. Indian Immunologicals Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Indian Immunologicals Genetically Engineered Vaccines for Livestock Product
 Table 104. Indian Immunologicals Recent Developments/Updates
 Table 105. China Animal Husbandry Industry Co.,Ltd. Company Information
 Table 106. China Animal Husbandry Industry Co.,Ltd. Description and Business Overview
 Table 107. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines for Livestock Product
 Table 109. China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
 Table 110. Yebio Bioengineering Co., Ltd Of Qingdao Company Information
 Table 111. Yebio Bioengineering Co., Ltd Of Qingdao Description and Business Overview
 Table 112. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines for Livestock Product
 Table 114. Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
 Table 115. Jinyu Bio-technology Co.,ltd. Company Information
 Table 116. Jinyu Bio-technology Co.,ltd. Description and Business Overview
 Table 117. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines for Livestock Product
 Table 119. Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
 Table 120. HVRI Company Information
 Table 121. HVRI Description and Business Overview
 Table 122. HVRI Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. HVRI Genetically Engineered Vaccines for Livestock Product
 Table 124. HVRI Recent Developments/Updates
 Table 125. Ringpu Biology Company Information
 Table 126. Ringpu Biology Description and Business Overview
 Table 127. Ringpu Biology Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Ringpu Biology Genetically Engineered Vaccines for Livestock Product
 Table 129. Ringpu Biology Recent Developments/Updates
 Table 130. Kyoto Biken Laboratories Company Information
 Table 131. Kyoto Biken Laboratories Description and Business Overview
 Table 132. Kyoto Biken Laboratories Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Kyoto Biken Laboratories Genetically Engineered Vaccines for Livestock Product
 Table 134. Kyoto Biken Laboratories Recent Developments/Updates
 Table 135. FATRO Company Information
 Table 136. FATRO Description and Business Overview
 Table 137. FATRO Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. FATRO Genetically Engineered Vaccines for Livestock Product
 Table 139. FATRO Recent Developments/Updates
 Table 140. Ceva Santé Animale Company Information
 Table 141. Ceva Santé Animale Description and Business Overview
 Table 142. Ceva Santé Animale Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Ceva Santé Animale Genetically Engineered Vaccines for Livestock Product
 Table 144. Ceva Santé Animale Recent Developments/Updates
 Table 145. Pulike Biological Engineering,Inc. Company Information
 Table 146. Pulike Biological Engineering,Inc. Description and Business Overview
 Table 147. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Livestock Product
 Table 149. Pulike Biological Engineering,Inc. Recent Developments/Updates
 Table 150. Wuhan Hvsen Biotechnology CO.,LTD Company Information
 Table 151. Wuhan Hvsen Biotechnology CO.,LTD Description and Business Overview
 Table 152. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Livestock Product
 Table 154. Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
 Table 155. Jinhe Biotechnology Co., Ltd. Company Information
 Table 156. Jinhe Biotechnology Co., Ltd. Description and Business Overview
 Table 157. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Livestock Product
 Table 159. Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
 Table 160. Shanghai Shen Lian Biomedical Corporation Company Information
 Table 161. Shanghai Shen Lian Biomedical Corporation Description and Business Overview
 Table 162. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines for Livestock Product
 Table 164. Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
 Table 165. Qingdao Vland Biotech INC. Company Information
 Table 166. Qingdao Vland Biotech INC. Description and Business Overview
 Table 167. Qingdao Vland Biotech INC. Genetically Engineered Vaccines for Livestock Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Qingdao Vland Biotech INC. Genetically Engineered Vaccines for Livestock Product
 Table 169. Qingdao Vland Biotech INC. Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Genetically Engineered Vaccines for Livestock Distributors List
 Table 173. Genetically Engineered Vaccines for Livestock Customers List
 Table 174. Genetically Engineered Vaccines for Livestock Market Trends
 Table 175. Genetically Engineered Vaccines for Livestock Market Drivers
 Table 176. Genetically Engineered Vaccines for Livestock Market Challenges
 Table 177. Genetically Engineered Vaccines for Livestock Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Genetically Engineered Vaccines for Livestock
 Figure 2. Global Genetically Engineered Vaccines for Livestock Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Genetically Engineered Vaccines for Livestock Market Share by Type: 2024 & 2031
 Figure 4. Genetic Recombinant Vaccine Product Picture
 Figure 5. Recombinant Subunit Vaccines Product Picture
 Figure 6. Genetic Vaccine Product Picture
 Figure 7. Global Genetically Engineered Vaccines for Livestock Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Genetically Engineered Vaccines for Livestock Market Share by Application: 2024 & 2031
 Figure 9. Pig
 Figure 10. Cattle
 Figure 11. Sheep
 Figure 12. Other
 Figure 13. Global Genetically Engineered Vaccines for Livestock Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Genetically Engineered Vaccines for Livestock Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Genetically Engineered Vaccines for Livestock Sales (2020-2031) & (K Units)
 Figure 16. Global Genetically Engineered Vaccines for Livestock Average Price (US$/Unit) & (2020-2031)
 Figure 17. Genetically Engineered Vaccines for Livestock Report Years Considered
 Figure 18. Genetically Engineered Vaccines for Livestock Sales Share by Manufacturers in 2024
 Figure 19. Global Genetically Engineered Vaccines for Livestock Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Genetically Engineered Vaccines for Livestock Players: Market Share by Revenue in Genetically Engineered Vaccines for Livestock in 2024
 Figure 21. Genetically Engineered Vaccines for Livestock Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Genetically Engineered Vaccines for Livestock Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Genetically Engineered Vaccines for Livestock Sales Market Share by Country (2020-2031)
 Figure 24. North America Genetically Engineered Vaccines for Livestock Revenue Market Share by Country (2020-2031)
 Figure 25. United States Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Genetically Engineered Vaccines for Livestock Sales Market Share by Country (2020-2031)
 Figure 28. Europe Genetically Engineered Vaccines for Livestock Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Genetically Engineered Vaccines for Livestock Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Genetically Engineered Vaccines for Livestock Revenue Market Share by Region (2020-2031)
 Figure 36. China Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Genetically Engineered Vaccines for Livestock Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Genetically Engineered Vaccines for Livestock Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Genetically Engineered Vaccines for Livestock Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Genetically Engineered Vaccines for Livestock Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Genetically Engineered Vaccines for Livestock Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Genetically Engineered Vaccines for Livestock by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Genetically Engineered Vaccines for Livestock by Type (2020-2031)
 Figure 55. Global Genetically Engineered Vaccines for Livestock Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Genetically Engineered Vaccines for Livestock by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Genetically Engineered Vaccines for Livestock by Application (2020-2031)
 Figure 58. Global Genetically Engineered Vaccines for Livestock Price (US$/Unit) by Application (2020-2031)
 Figure 59. Genetically Engineered Vaccines for Livestock Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart